GlassScriptPhysician profile
Donald C Kitt
NPI 1477641090
$2,092.70
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $368 · 2020: $1,014 · 2021: $711.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sk Life Science, INC. | $331.98 | 2020-2021 | |
| Neurocrine Biosciences, INC. | $319.16 | 2020-2021 | |
| Amgen INC. | $215.20 | 2019-2021 | |
| Boston Scientific Corporation | $145.53 | 2020 | |
| Lundbeck LLC | $134.07 | 2019-2021 | |
| Sunovion Pharmaceuticals INC. | $117.22 | 2019-2020 | |
| Kyowa Kirin, INC. | $113.88 | 2020-2021 | |
| Teva Pharmaceuticals USA, INC. | $95.75 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $89.61 | 2019-2021 | |
| Allergan, INC. | $67.71 | 2019-2020 | |
| Biogen, INC. | $62.56 | 2020-2021 | |
| Ucb, INC. | $58.93 | 2020 | |
| Avanir Pharmaceuticals, INC. | $56.33 | 2019-2020 | |
| Arbor Pharmaceuticals, INC. | $55.20 | 2020-2021 | |
| Acadia Pharmaceuticals INC | $38.84 | 2019-2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceuticals, INC. | $32.27 | 2020-2021 | |
| Mallinckrodt Hospital Products INC. | $29.11 | 2020 | |
| Amneal Pharmaceuticals LLC | $24.03 | 2021 | |
| Alexion Pharmaceuticals, INC. | $23.51 | 2020 | |
| Lilly USA, LLC | $22.85 | 2019 | |
| Supernus Pharmaceuticals, INC. | $21.44 | 2021 | |
| Mdd US Operations, LLC | $21.06 | 2019 | |
| Almatica Pharma LLC | $16.46 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donald Kitt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.